QLS1304
Advanced ER+/HER2- Breast Cancer
Qilu Pharmaceutical Co., Ltd.Phase 1/2
—
Rating in progress
QLS1304 in Advanced ER+/HER2- Breast Cancer is in the Floatz rating universe. The engine has not yet published a v0.2 rating for this asset. This page will update automatically once scoring completes.
Methodology v0.2 · Active